chang recommend
upgrad outperform make scent
upgrad outperform price target
tsr think improv organ growth momentum fulli
factor consensu investor fear raw materi inflat
particularli citral overdon whole sector saw good
organ growth momentum notabl pickup amongst multi-national
custom fragranc side expect momentum
continu albeit usual season forecast
ep growth put us ahead consensu
also make assumpt tailwind tax reform
consensu may fulli factor yet share trade
pe ebitda yield line symris
discount givaudan pe ebitda yield
anti-consensu upgrad peck order givn
note one least love stock us chem
consensu neutral/sel rate whilst qualiti stock includ
continu trade elev premium cyclic still
think look compel within qualiti complex share
under-perform symris consum chem usd term
past quarter perform line givaudan within
upgrad top peck order close follow symris
outperform givaudan whilst see similar upsid
price target symris see upsid
consensu plu favour set note much
easier comp fx tailwind notabl eurusd givaudan
least attract view alreadi trade premium peer
potenti expos recent citral inflat even temporari
issu event givn jan mid feb march
raw mat inflat dj vu citral ignor
start peak investor concern raw materi inflat
 vanilla citru oil deriv biggest concern
time argu fear overdon given industri
track record price passthrough inde first month
 averag lost gross margin despit key raw
vanilla doubl price context industri gross
margin fell last time saw signific inflat
feel like dj vu fear around rise oil citral
price latter caus forc majeur basf one industri
main supplier acknowledg inflationari headwind think
citral dynam particular ignor still argu
industri price power albeit lag therefor assum
margin improv vs citral use produc variou
aroma chemic includ synthet citru menthol therefor
like one larger raw within industri basket
raw materi think symris may better posit
givaudan deal inflationari pressure/suppli shortag
intern citral product capabl symris menthol
busi could benefit higher price potenti volum key
menthol competitor basf unabl suppli market asid
see dsm vitamin busi biggest beneficiari basf
pleas see analyst certif import disclosur page report evercor isi affili seek busi
compani cover research report investor awar firm may conflict interest could affect
object report investor consid report singl factor make invest decis
six chart
expect catch givaudan organ
top-line symris bottom line mid teen
ep growth
qualiti chemic mean cheap within
sector qualiti pe premium cyclic pe
within qualiti one rel
underperform share price perform usd
like industri structur big player bolt
opportun space larg consolid deal
 gross margin remain rel stabl
despit oil price raw mat volatil
raw materi inflat debat
 industri histori pass raw materi price chang albeit lag start peak investor
concern raw materi inflat vanilla citru oil deriv biggest concern time argu
fear overdon given industri track record price passthrough inde first month
averag lost gross margin despit key raw vanilla doubl price context industri gross
margin fell last time saw signific inflat
renew investor fear around raw materi feel like dj vu fear around rise oil citral price
 latter caus forc majeur basf one industri main supplier acknowledg inflationari headwind think
citral dynam particular ignor still argu industri price power albeit lag therefor
assum margin improv vs
what go citral price citral use produc variou aroma chemic includ synthet citru menthol
therefor like one larger raw within industri basket raw materi think symris may
better posit givaudan deal inflationari pressure/suppli shortag intern citral product capabl
symris menthol busi could benefit higher price potenti volum key menthol competitor basf unabl
suppli market asid see dsm vitamin busi biggest beneficiari basf citral forc majeur
 gross margin remain rel stabl
natur volatil
ebitda margin even stabl
givaudan raw mat split compani sourc
 four domin player scope one big consolid deal
would expect see consolid consum chem far rel quiet apart
small bolt on big multi-national mnc custom increas pressur smaller local
region competit well activ mnc tri put increas pressur
supplier exampl ask volum rebat think continu pressur and/or return lower
growth environ could trigger consolid consum chem industri see scope one
last deal low growth environ ag gase ultim trigger consolid industri
see strateg valu symris potenti lowest anti-trust hurdl smallest big
amongst list player ultim think consolid industri whatev combin could
help price power
like industri structur big player bolt
opportun space larg consolid
headquartersmarket cap usd sale usd estim market hasegawajapan flavor kelkar aroma chemic germani januari
hansen organ custom weight year roll hansen organ hansen organ custom weight year roll hansen organ custom weight januari
us debt yield yield capital-expenditure margin yield yield januari
us neutral volumeof priceof growth month roll neutral volumeof priceof growth month roll neutral growth month roll oper oper group group op profit januari
us y/ygross admin charg acquisit relat profit except oper margin division ebitda ppa acquisit relat tax post net control interestsnet net incom alloc pr purchas restrict incom ep basic dilut ep dilut ep pre ppa januari
price estimate volume estimate oper price ingr rationalis cost cut pre tax save half addit save adj op profit exclud cost new product programnet fix michael fragranc resourc powder incent compens phase toward impact manufactur issu assum product recalloper profit profit margin ebitda januari
us work incom expenditur expenditur intang -- -- -financi busi decreas decreas begin chang net chang year januari
us cash flow asset incr nopat adjustments-associates-minor interests-oth provisions-equ per januari
gener deriv target price use dcf model cross-check part ev/ebitda price-to-earnings
yield either combin isol consid chemic valuat broad global industri context well rel
compani histori assess futur earn growth oper margin free cash flow gener return capit
employ light industri dynam barrier entri regul context captur dcf term input
 use explicit forecast fade growth return appropri also discount rate
determin whether compani deserv higher lower multipl
chemic compani global cyclic expos highli complex busi result expos posit
neg risk broader polit econom social factor raw materi price currenc signific driver
financi perform also face oper execut risk failur adequ assess exposur risk
time fashion may result estimates/forecast prove high and/or low
articl articl
time dissemin januari et
analyst nicola tang laurent favr primarili respons prepar research report attest follow
view opinion render research report reflect person view subject compani issuer part
research analyst compens directli relat specif recommend view research report
analyst nicola tang laurent favr non-u analyst contribut research report non-u analyst may associ
person evercor group therefor regist qualifi nyse finra research analyst may subject
finra rule restrict commun subject compani public appear trade secur held analyst
